 Connection
Karoline Schnizer-Luger to Poly (ADP-Ribose) Polymerase-1
This is a "connection" page, showing publications Karoline Schnizer-Luger has written about Poly (ADP-Ribose) Polymerase-1.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.449 |
|
|
|
-
Rudolph J, Muthurajan UM, Palacio M, Mahadevan J, Roberts G, Erbse AH, Dyer PN, Luger K. The BRCT domain of PARP1 binds intact DNA and mediates intrastrand transfer. Mol Cell. 2021 12 16; 81(24):4994-5006.e5.
Score: 0.359
-
Rudolph J, Roberts G, Luger K. Histone Parylation factor 1 contributes to the inhibition of PARP1 by cancer drugs. Nat Commun. 2021 02 02; 12(1):736.
Score: 0.338
-
Mahadevan J, Bowerman S, Luger K. Quantitating repair protein accumulation at DNA lesions: Past, present, and future. DNA Repair (Amst). 2019 09; 81:102650.
Score: 0.303
-
Mahadevan J, Rudolph J, Jha A, Tay JW, Dragavon J, Grumstrup EM, Luger K. Q-FADD: A Mechanistic Approach for Modeling the Accumulation of Proteins at Sites of DNA Damage. Biophys J. 2019 06 04; 116(11):2224-2233.
Score: 0.299
-
Rudolph J, Luger K. PARP1 and HPF1 team up to flag down DNA-repair machinery. Nat Struct Mol Biol. 2023 05; 30(5):568-569.
Score: 0.099
-
Kellett T, Noor R, Zhou Q, Esquer H, Sala R, Stojanovic P, Rudolph J, Luger K, LaBarbera DV. HTS discovery of PARP1-HPF1 complex inhibitors in cancer. SLAS Discov. 2023 12; 28(8):394-401.
Score: 0.051
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|